Chronic Graft-versus-host disease - Globe Thesis

Keyword [Chronic Graft-versus-host disease] Result: 41 - 59 \| Page: 3 of 3
41.	Study Of Bcl-6 Downregulation To Prevent Chronic Graft Versus Host Disease
42.	Clinical Efficacy And Safety Of Ruxolitinib In The Treatment Of Chronic Graft-versus-host Disease
43.	Analysis Of Risk Factors For Pulmonary Chronic Graft-versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation
44.	Establishment And Indentification Of A Mice Model Of Chronic Graft-verse-hoet Disease With Oral Lesions
45.	The Clinical Study Of Chronic Graft-versus-host Disease Following Haploidentical Transplantation Combined Infusion With A Third Party Cord Blood
46.	Clinical Observation Of Sirolimus In The Treatment Of Refractory Chronic Graft-Versus-Host-Disease
47.	The Role Of Extrafollicular Helper T-like Cells In Patient With Chronic Graft-Versus-host Disease
48.	A Meta-analysis Of The Efficacy Of Mesenchymal Stem Cells In The Treatment Of Chronic Graft Versus Host Disease
49.	Study On The Risk Factors And Diagnostic Biomarkers Of Chronic Graft-versus-host Disease
50.	The Role Of Tfh Cell And B Cell In The Progression Of Chronic Graft Versus Host Disease In Human
51.	Preliminary Study On Ruxolitinib In The Salvage Treatment Of Refractory Pulmonary Chronic Graft-Versus-Host Disease(Bronchiolitis Obliterans Syndrome)
52.	The Role And Mechanism Of BET Inhibitor I-BET151 In Chronic Graft-versus-host Disease After Allogeneic Hematopoietic Stem Cell Transplantation
53.	Symptoms, functional status, and altered immunity in survivors of allogeneic hematopoietic stem cell transplantation with chronic graft-versus-host disease (cGVHD)
54.	Symptoms, Cytokines, and Quality of Life of Patients with Chronic Graft-versus-Host Disease following Allogeneic Hematopoietic Stem Cell Transplantation
55.	The Role Of Nestin+Mesenchymal Stem Cells(MSCs) In Bone Marrow Chronic Graft-Versus-Host Disease
56.	Fecal Microbiota Transplantation For Acute And Chronic Graft-versus-host Disease:A Pilot Study And Systematic Review
57.	Alleviation Of Murine Sclerodermatous Chronic Graft Versus Host Disease By The Nrf2 Activator Mangiferin
58.	Sirolimus In Combination With Calcineurin Inhibitors For Hormone Resistant/dependentcGVHD
59.	Fibronectin Regulates Chronic Graft-versus-host Disease By Influencing Infiltration Of Alternatively Activated Macrophages
<<First <Prev Next> Last>> Jump to